{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:47:51Z","timestamp":1791906471300,"version":"4.3.4"},"reference-count":77,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C02058"],"award-info":[{"award-number":["2025C02058"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32000799"],"award-info":[{"award-number":["32000799"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LD25H300001"],"award-info":[{"award-number":["LD25H300001"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LZ26H160004"],"award-info":[{"award-number":["LZ26H160004"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.trecan.2026.06.007","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T20:32:58Z","timestamp":1783024378000},"page":"950-961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Itaconate in cancer immunity: Evidence, ambiguities, and translational barriers"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1022-8882","authenticated-orcid":false,"given":"Juntong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3288-3661","authenticated-orcid":false,"given":"Ruichen","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6369-1317","authenticated-orcid":false,"given":"Xudong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5447-8978","authenticated-orcid":false,"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bufu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1351-7896","authenticated-orcid":false,"given":"Yicheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-1337","authenticated-orcid":false,"given":"Guoqing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9957-077X","authenticated-orcid":false,"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2026.06.007_bb0005","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0010","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cmet.2024.11.012","article-title":"Itaconate transporter SLC13A3 confers immunotherapy resistance via alkylation-mediated stabilization of PD-L1","volume":"37","author":"Fan","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.trecan.2026.06.007_bb0015","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1038\/s42255-022-00676-9","article-title":"Myeloid-derived itaconate suppresses cytotoxic CD8+ T cells and promotes tumour growth","volume":"4","author":"Zhao","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.trecan.2026.06.007_bb0020","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1158\/0008-5472.CAN-24-2982","article-title":"Macrophage-derived itaconate suppresses dendritic cell function to promote acquired resistance to anti-PD-1 immunotherapy","volume":"85","author":"Yang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2026.06.007_bb0025","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1038\/s41467-023-43988-4","article-title":"Itaconate promotes hepatocellular carcinoma progression by epigenetic induction of CD8+ T-cell exhaustion","volume":"14","author":"Gu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.06.007_bb0030","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.ccell.2024.10.010","article-title":"Itaconate transporter SLC13A3 impairs tumor immunity via endowing ferroptosis resistance","volume":"42","author":"Lin","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.06.007_bb0035","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.1038\/s41467-023-41470-9","article-title":"Metabolic reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.06.007_bb0040","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.cmet.2023.09.004","article-title":"Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1","volume":"35","author":"Zhao","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.trecan.2026.06.007_bb0045","doi-asserted-by":"crossref","first-page":"7820","DOI":"10.1073\/pnas.1218599110","article-title":"Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production","volume":"110","author":"Michelucci","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.trecan.2026.06.007_bb0050","doi-asserted-by":"crossref","first-page":"16386","DOI":"10.1021\/ja2070889","article-title":"Itaconic acid is a mammalian metabolite induced during macrophage activation","volume":"133","author":"Strelko","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.trecan.2026.06.007_bb0055","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/s42255-024-01092-x","article-title":"Metabolic messengers: itaconate","volume":"6","author":"McGettrick","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.trecan.2026.06.007_bb0060","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tem.2024.02.004","article-title":"Itaconate in host inflammation and defense","volume":"35","author":"Ye","year":"2024","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.trecan.2026.06.007_bb0065","article-title":"Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy","volume":"9","author":"Chen","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.trecan.2026.06.007_bb0070","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cmet.2023.12.015","article-title":"ABCG2 is an itaconate exporter that limits antibacterial innate immunity by alleviating TFEB-dependent lysosomal biogenesis","volume":"36","author":"Chen","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.trecan.2026.06.007_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123245","article-title":"The role of ABCG2 in health and disease: linking cancer therapy resistance and other disorders","volume":"360","author":"El-Ashmawy","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.trecan.2026.06.007_bb0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nature25986","article-title":"Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1","volume":"556","author":"Mills","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.06.007_bb0085","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s42255-020-0210-0","article-title":"Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages","volume":"2","author":"Swain","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.trecan.2026.06.007_bb0090","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1074\/jbc.C117.775270","article-title":"Dimethyl itaconate is not metabolized into itaconate intracellularly","volume":"292","author":"ElAzzouny","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2026.06.007_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113040","article-title":"4-Octyl itaconate restricts STING activation by blocking its palmitoylation","volume":"42","author":"Su","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.trecan.2026.06.007_bb0100","doi-asserted-by":"crossref","DOI":"10.1172\/JCI160463","article-title":"The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response","volume":"133","author":"Zeng","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2026.06.007_bb0105","article-title":"Immunotherapy: reshape the tumor immune microenvironment","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0110","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.3389\/fimmu.2018.02909","article-title":"Immunomodulation of the tumor microenvironment: turn foe into friend","volume":"9","author":"Locy","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13045-019-0760-3","article-title":"Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications","volume":"12","author":"Lin","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0120","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","article-title":"Decoding the spatiotemporal heterogeneity of tumor-associated macrophages","volume":"23","author":"Chu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.trecan.2026.06.007_bb0125","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","article-title":"Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells","volume":"595","author":"Casanova-Acebes","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.06.007_bb0130","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.trecan.2026.06.007_bb0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2026.06.007_bb0140","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-017-0430-2","article-title":"Tumor-associated macrophages: from basic research to clinical application","volume":"10","author":"Yang","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0150","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41467-019-11788-4","article-title":"Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry","volume":"10","author":"Huang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.06.007_bb0155","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41590-023-01592-0","article-title":"Specialization determines outcomes in inflammation and cancer","volume":"24","author":"Sica","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0160","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41419-024-07074-x","article-title":"Novel FABP4+C1q+ macrophages enhance antitumor immunity and associated with response to neoadjuvant pembrolizumab and chemotherapy in NSCLC via AMPK\/JAK\/STAT axis","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2026.06.007_bb0165","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/2159-8290.CD-23-1300","article-title":"Spatially segregated macrophage populations predict distinct outcomes in colon cancer","volume":"14","author":"Matusiak","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.06.007_bb0170","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1038\/s41467-023-41095-y","article-title":"THBS1-producing tumor-infiltrating monocyte-like cells contribute to immunosuppression and metastasis in colorectal cancer","volume":"14","author":"Omatsu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.06.007_bb0175","article-title":"Metabolic characterization of polarized M1 and M2 bone marrow-derived macrophages using real-time extracellular flux analysis","volume":"105","author":"Van den Bossche","year":"2015","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.trecan.2026.06.007_bb0180","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41423-021-00791-9","article-title":"Metabolism of tissue macrophages in homeostasis and pathology","volume":"19","author":"Wculek","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115332","article-title":"Immunometabolism of tumor-associated macrophages: a therapeutic perspective","volume":"220","author":"Karimova","year":"2025","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.trecan.2026.06.007_bb0190","doi-asserted-by":"crossref","first-page":"C1070","DOI":"10.1152\/ajpcell.00126.2021","article-title":"Mitochondrial metabolism in macrophages","volume":"321","author":"Nassef","year":"2021","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0195","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.copbio.2021.01.020","article-title":"Complexity of macrophage metabolism in infection","volume":"68","author":"He","year":"2021","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0200","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1158\/2159-8290.CD-24-0199","article-title":"ROR\u03b3 bridges cancer-driven lipid dysmetabolism and myeloid immunosuppression","volume":"15","author":"Bleve","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.06.007_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166530","article-title":"Itaconate controls its own synthesis via feedback-inhibition of reverse TCA cycle activity at IDH2","volume":"1868","author":"Heinz","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.trecan.2026.06.007_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tips.2022.12.003","article-title":"Advances and challenges in therapeutic targeting of NRF2","volume":"44","author":"Dinkova-Kostova","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.trecan.2026.06.007_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734229","article-title":"Reactive oxygen species in macrophages: sources and targets","volume":"12","author":"Canton","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0220","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3390\/antiox10060847","article-title":"Nrf2 regulates anti-inflammatory A20 deubiquitinase induction by LPS in macrophages in contextual manner","volume":"10","author":"Potteti","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.trecan.2026.06.007_bb0225","article-title":"Macrophages are activated toward phagocytic lymphoma cell clearance by pentose phosphate pathway inhibition","volume":"5","author":"Beielstein","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.trecan.2026.06.007_bb0230","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","article-title":"Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation","volume":"24","author":"Lampropoulou","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.trecan.2026.06.007_bb0235","first-page":"849","article-title":"Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies","volume":"21","author":"Zhang","year":"2024","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.trecan.2026.06.007_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.868695","article-title":"The evasion mechanisms of cancer immunity and drug intervention in the tumor microenvironment","volume":"13","author":"Kim","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0245","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2026.06.007_bb0250","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.trecan.2026.06.007_bb0255","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.trecan.2026.06.007_bb0260","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined nivolumab and ipilimumab or monotherapy in untreated melanoma","volume":"373","author":"Larkin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2026.06.007_bb0265","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev-immunol-101819-024752","article-title":"Beyond the barrier: unraveling the mechanisms of immunotherapy resistance","volume":"42","author":"Bell","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0270","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1038\/s41467-023-36979-y","article-title":"The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma","volume":"14","author":"Lim","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2026.06.007_bb0275","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.trecan.2026.06.007_bb0280","article-title":"PD-1+ IFN-\u03b3+ subset of CD8+ T cell in circulation predicts response to anti-PD-1 therapy in NSCLC","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0285","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2026.06.007_bb0290","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.trecan.2026.06.007_bb0295","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41556-019-0373-7","article-title":"Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms","volume":"21","author":"Kim","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0300","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41419-019-1984-4","article-title":"The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis","volume":"10","author":"Wang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2026.06.007_bb0305","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","article-title":"Glutaminolysis and transferrin regulate ferroptosis","volume":"59","author":"Gao","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.trecan.2026.06.007_bb0310","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/1878-0261.13649","article-title":"A guide to ferroptosis in cancer","volume":"18","author":"Yapici","year":"2024","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0315","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41420-023-01475-1","article-title":"\u03b1-KG inhibits tumor growth of diffuse large B-cell lymphoma by inducing ROS and TP53-mediated ferroptosis","volume":"9","author":"Cai","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.trecan.2026.06.007_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103711","article-title":"Radiation-induced upregulation of itaconate in macrophages promotes the radioresistance of non-small cell lung cancer by stabilizing NRF2 protein and suppressing immune response","volume":"85","author":"Che","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0325","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.7150\/thno.110305","article-title":"Boosting mRNA cancer vaccine efficacy via targeting Irg1 on macrophages in lymph nodes","volume":"15","author":"Wei","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.trecan.2026.06.007_bb0330","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1038\/s44318-024-00217-y","article-title":"Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity","volume":"43","author":"Wang","year":"2024","journal-title":"EMBO J."},{"key":"10.1016\/j.trecan.2026.06.007_bb0335","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.62347\/LHYO6433","article-title":"Itaconate targets the ERK2 signal to suppress estrogen receptor-positive breast cancer cell growth","volume":"15","author":"Wang","year":"2025","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.trecan.2026.06.007_bb0340","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00109-020-01963-2","article-title":"The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancer","volume":"98","author":"Wang","year":"2020","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.trecan.2026.06.007_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114301","article-title":"4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer","volume":"159","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.trecan.2026.06.007_bb0350","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/ars.2024.0629","article-title":"4-Octyl itaconate attenuates cell proliferation by cellular senescence via glutathione metabolism disorders and mitochondrial dysfunction in melanoma","volume":"42","author":"Hayashi","year":"2025","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.trecan.2026.06.007_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119847","article-title":"Antitumor effect of dimethyl itaconate on thymic carcinoma by targeting LDHA-mTOR axis","volume":"282","author":"Hayashi","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.trecan.2026.06.007_bb0360","article-title":"Preclinical evaluation of dimethyl itaconate against hepatocellular carcinoma via activation of the e\/iNOS-mediated NF-\u03baB-dependent apoptotic pathway","volume":"12","author":"Gautam","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0365","doi-asserted-by":"crossref","first-page":"5699","DOI":"10.2147\/JIR.S516085","article-title":"4-octyl itaconate modulates dendritic cells function and tumor immunity via NRF2 activation","volume":"18","author":"Zhu","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.trecan.2026.06.007_bb0370","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/annonc\/mdf125","article-title":"Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention","volume":"13","author":"Davies","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.trecan.2026.06.007_bb0375","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mam.2012.12.001","article-title":"SLC13 family of Na+-coupled di- and tri-carboxylate\/sulfate transporters","volume":"34","author":"Bergeron","year":"2013","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.trecan.2026.06.007_bb0380","article-title":"Amino acid positions near the active site determine the reduced activity of human ACOD1 compared to murine ACOD1","volume":"13","author":"Chen","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2026.06.007_bb0385","doi-asserted-by":"crossref","first-page":"20644","DOI":"10.1073\/pnas.1908770116","article-title":"Crystal structure of cis-aconitate decarboxylase reveals the impact of naturally occurring human mutations on itaconate synthesis","volume":"116","author":"Chen","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803326001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:13:18Z","timestamp":1791904398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803326001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2405803326001354"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2026.06.007","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Itaconate in cancer immunity: Evidence, ambiguities, and translational barriers","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2026.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}